APM vs ARDX

Aptorum Group Limited vs Ardelyx, Inc. — Valuation Comparison 2026

APM

Biotechnology
Aptorum Group Limited
Quality
2.2
out of 10
Value Trap
Price
$0.84
Last close
Models
10/13
Active
VS

ARDX

Biotechnology
Ardelyx, Inc.
Quality
6.1
out of 10
Value Trap
30
LOW
Price
$6.25
Last close
Models
11/13
Active

Model-by-Model Comparison

ModelType APM Fair ValueAPM Upside ARDX Fair ValueARDX Upside
Bayesian DCF Intrinsic $0.22 -73.6% $1.41 -77.4%
Earnings Power Value Intrinsic $0.06 -92.8% $1.72 -75.0%
EROIC Spread Intrinsic $•••.•• ••.•% $•••.•• ••.•%
First Chicago Scenario $•••.•• ••.•% $•••.•• ••.•%
ML-RIV Intrinsic $•••.•• ••.•% $•••.•• ••.•%
Dynamic NAV Asset-Based $•••.•• ••.•% $•••.•• ••.•%
PWERM Option-Based $•••.•• ••.•% $•••.•• ••.•%
Regime Cross-Sectional Relative $•••.•• ••.•% $•••.•• ••.•%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
FTNN Topology Relative $•••.•• ••.•% $•••.•• ••.•%
🔒

Unlock Full 13-Model Comparison

Access all valuation models for APM vs ARDX — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

APM vs ARDX — Which Stock Is More Undervalued?

ARDX scores higher with a 6.1/10 quality rating vs APM's 2.2/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Aptorum Group Limited (APM) and Ardelyx, Inc. (ARDX) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

APM currently trades at $0.84 with a QOC of 2.2/10, while ARDX trades at $6.25 with a QOC of 6.1/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).